henhaobio
Sign in

Molecular Therapy — Nucleic AcidsImmunologyPeer-reviewed journal article

Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells

Ana-Maria NitulescuiD, Weijie DuiD, Viktor GlaseriD, Jonas KathiD, Eric J. AirdiD, Grégoire CullotiD, Robert GreensmithiD, Nanna S. MikkelseniD, Maik SteiniD, Rasmus Otkjær BakiD, Michael M. KaminskiiD, Jacob E. CorniD, Dimitrios L. WagneriD

PDFDOIPreprint

Abstract

Non-viral gene editing via CRISPR-Cas12a offers an alternative to Cas9-based methods, providing better targeting of AT-rich regions, simplified guide RNA manufacturing, and high specificity. However, the efficacy of editing outcomes is subject to various factors, with template format playing a crucial role. Currently, the predominant non-viral template format for inducing homology-directed repair (HDR) after nuclease-induced DNA breaks is double-stranded DNA (dsDNA), which is toxic when transfected at high doses. Previous studies have demonstrated that using single-stranded DNA (ssDNA) with flanking double-stranded Cas-target-sequences (CTS) as a repair template for Cas9-mediated gene editing can mitigate this toxicity and increase knock-in efficiency. Here, we investigate CTS design for AsCas12a Ultra by exploring PAM orientation and binding requirements of the Cas12a-crRNA complex. Additionally, we rule out in vitro ssDNase activity of AsCas12a Ultra under cell-physiological Mg2+ conditions. Finally, we showcase the advantage of using ssDNA with double-stranded CTS end modifications (ssCTS) at high doses for delivering clinically relevant transgenes of varying sizes into three T-cell receptor-CD3 complex genes (TRAC, CD3{zeta}, CD3{varepsilon}), achieving up to 90% knock-in rates for a 0.8kb insert at the CD3{varepsilon} locus. Overall, AsCas12a Ultra and ssCTS donors represent a platform for highly efficient knock-in in primary human T cells with minimal toxicity.

Citations
9
FWCI
2.23
Field percentile
top 11%

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISShy '21Iyer '19Schubert '21Luk '22Thibault '25Kim '21
70% semantic matchSynthetic Biology
Brian Rudolph Shy, Vivasvan S. Vykunta, Alvin S. Ha+15 more·bioRxiv·Sep 2, 2021· 17 citations